Total Payments
$84,740
2024 Payments
$8,901
Companies
15
Transactions
119
Medicare Patients
634
Medicare Billing
$51,794
Payment Breakdown by Category
Consulting$73,747 (87.0%)
Other$4,165 (4.9%)
Travel$2,861 (3.4%)
Research$2,625 (3.1%)
Food & Beverage$1,343 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $73,747 | 57 | 87.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,715 | 4 | 4.4% |
| Travel and Lodging | $2,861 | 15 | 3.4% |
| Unspecified | $2,625 | 15 | 3.1% |
| Food and Beverage | $1,343 | 27 | 1.6% |
| Honoraria | $450.00 | 1 | 0.5% |
Payments by Type
General
$82,115
104 transactions
Research
$2,625
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $36,404 | 72 | $0 (2024) |
| F. Hoffmann-La Roche AG | $14,418 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $8,959 | 11 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $7,650 | 7 | $0 (2024) |
| SANOFI US SERVICES INC. | $6,456 | 5 | $0 (2022) |
| Eli Lilly and Company | $5,075 | 3 | $0 (2024) |
| Partner Therapeutics, Inc. | $2,500 | 1 | $0 (2020) |
| Theravance Biopharma, Inc. | $1,500 | 1 | $0 (2018) |
| Curium US LLC | $1,369 | 5 | $0 (2024) |
| InSightec,Inc | $180.05 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,901 | 12 | F. Hoffmann-La Roche AG ($3,278) |
| 2023 | $20,992 | 21 | F. Hoffmann-La Roche AG ($6,941) |
| 2022 | $9,293 | 14 | ABBVIE INC. ($5,703) |
| 2021 | $12,313 | 11 | F. Hoffmann-La Roche AG ($4,200) |
| 2020 | $11,979 | 9 | AbbVie Inc. ($6,875) |
| 2019 | $3,472 | 16 | SANOFI-AVENTIS U.S. LLC ($2,622) |
| 2018 | $11,185 | 13 | AbbVie, Inc. ($8,374) |
| 2017 | $6,605 | 23 | AbbVie, Inc. ($5,174) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | VYALEV (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | VYALEV (Drug) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,450.00 | General |
| 10/01/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $2,932.50 | General |
| 10/01/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $132.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.39 | General |
| Category: Neuropsychiatry | ||||||
| 07/17/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 07/01/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $345.00 | General |
| 06/05/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $725.00 | General |
| 06/03/2024 | Curium US LLC | — | Honoraria | Cash or cash equivalent | $450.00 | General |
| 04/04/2024 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 12/21/2023 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 11/08/2023 | Curium US LLC | Ioflupane I 123 (Drug) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Injection, Solution | ||||||
| 10/19/2023 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 10/19/2023 | AbbVie Inc. | — | Travel and Lodging | In-kind items and services | $39.90 | General |
| 09/29/2023 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 09/12/2023 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| 09/01/2023 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $5,520.00 | General |
| 08/30/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $67.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $1,380.00 | General |
| 08/28/2023 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $40.60 | General |
| 08/28/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: Parkinson's Disease | ||||||
| 08/03/2023 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 08/02/2023 | Curium US LLC | Ioflupane I 123 (Drug) | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| Category: Injection, Solution | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M15-741 | AbbVie, Inc. | $849.87 | 13 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 131 | 132 | $44,149 | $11,199 |
| 2022 | 7 | 195 | 237 | $68,854 | $17,459 |
| 2021 | 3 | 157 | 161 | $52,153 | $13,993 |
| 2020 | 4 | 151 | 154 | $39,466 | $9,142 |
Total Patients
634
Total Services
684
Medicare Billing
$51,794
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 35 | 35 | $17,815 | $4,425 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 72 | 73 | $17,958 | $4,419 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 24 | 24 | $8,376 | $2,355 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 98 | 100 | $24,600 | $6,464 | 26.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 44 | $13,068 | $3,458 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 26 | 27 | $9,423 | $2,674 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $8,653 | $1,898 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $6,576 | $1,221 | 18.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 21 | $4,410 | $1,121 | 25.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 12 | 12 | $2,124 | $623.00 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 88 | 92 | $22,632 | $5,894 | 26.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 35 | 35 | $12,215 | $4,052 | 33.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 34 | 34 | $17,306 | $4,047 | 23.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 98 | 100 | $24,600 | $5,145 | 20.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 23 | 23 | $11,707 | $2,638 | 22.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 14 | 15 | $1,704 | $781.54 | 45.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 16 | 16 | $1,455 | $577.89 | 39.7% |
About David Standaert
David Standaert is a Neurology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588654495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Standaert has received a total of $84,740 in payments from pharmaceutical and medical device companies, with $8,901 received in 2024. These payments were reported across 119 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($73,747).
As a Medicare-enrolled provider, Standaert has provided services to 634 Medicare beneficiaries, totaling 684 services with total Medicare billing of $51,794. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Birmingham, AL
- Active Since 10/24/2005
- Last Updated 02/01/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1588654495
Products in Payments
- GZ402671 (Drug) $3,933
- DUOPA (Drug) $2,978
- Leukine (Drug) $2,500
- Duopa (Drug) $2,025
- VYALEV (Drug) $1,350
- Ioflupane I 123 (Drug) $900.00
- NORTHERA (Drug) $91.98
- INGREZZA (Drug) $37.39
- NOURIANZ (Drug) $37.30
- INBRIJA (Drug) $34.78
- RYTARY (Drug) $27.86
- Detectnet (Drug) $19.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Birmingham
Dr. Diane Counce, Md, MD
Neurology — Payments: $1.1M
Neurology $1.1M
Jerzy Szaflarski
Neurology — Payments: $253,912
Neurology $253,912
Victor Sung
Neurology — Payments: $167,572
Neurology $167,572
Benjamin Jones, M.d, M.D
Neurology — Payments: $148,235
Neurology $148,235
Raymond Faught, Md, MD
Neurology — Payments: $122,322
Neurology $122,322
Shin Oh, Md, MD
Neurology — Payments: $99,777
Neurology $99,777